Walleye Capital’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Walleye Capital's CDLX Position: Q1 2026 in Review
Walleye Capital sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 1,075 shares — an estimated $12.4K sold.
Walleye Capital first reported a position in CDLX in Q4 2019 and held it in 11 quarters. The position peaked at $766K in Q1 2023. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Walleye Capital reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
- Walleye Capital sold 1,075 Cardlytics shares in Q1 2026, an estimated $12.4K.
- Walleye Capital first reported a position in Cardlytics in Q4 2019 and held it in 11 quarters.
- Walleye Capital's Cardlytics position peaked at $766K in Q1 2023.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.